我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

A brief overview to systems biology in toxicology: The journey from in to vivo, in-vitro and ?omics

Akira Sugawara

Toxicology aims to comprehend and envisage the adverse outcomes of chemicals and xenobiotics on the biological system. Predicting toxicity on the biological system is a complex and immense process. In-vivo, in-vitro, pre-, clinical and –omics level experimental approaches have been utilized to describe the toxicological impact of these chemicals and this has generated a vast wealth of data. Hence, there now exist a need for a system that can interrelate and provide accurate and robust extrapolation of these data across various systems. Therefore, it is essential to re-shift our notion from empirical, animal-based testing to a mechanistic understanding. Systems biology is one such system that can extrapolate and interrelate these vast biological system data. Systems biology is a computational and mathematical modelling approach developed to understand interrelationships between networks of biological systems. The use of systems biology to answer toxicology-related questions is termed as systems toxicology. In this review we will look at the standard and classical toxicology experimentations and how we can use mechanistic data (systems biology) to answer toxicology-related questions using systems toxicology and what are the future opportunities in systems toxicology. The advancement of systems toxicology heralds new dawn of technologies that will aid in our quest to better comprehend and envisage the adverse outcomes of chemicals and xenobiotics on the biological system.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。